Analytical Models to Optimize Tacrolimus Dosing in Solid Organ Transplantation: A Systematic Review
Authors:
- Elmira AmooeiEAElmira Amooei
- Nandini BiyaniNBNandini Biyani
- Amos BuhABAmos Buh
- Martin M. KlamrowskiMKMartin M. Klamrowski
- Nawaf M. AlyahyaNANawaf M. Alyahya
- Christopher R. McCuddenCMChristopher R. McCudden
- James R. GreenJGJames R. Green
- Babak RashidiBRBabak Rashidi
- Haya AlmuziraiHAHaya Almuzirai
- Stephanie HoarSHStephanie Hoar
- Ayub AkbariAAAyub Akbari
- Gregory L. HundemerGHGregory L. Hundemer
Open Access
- 31 March 2026
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (4) , 430
Abstract
Background: Tacrolimus dose optimization remains challenging due to its narrow therapeutic range and multiple influencing variables. This systematic review aimed to identify effective analytical modeling techniques for optimal tacrolimus dose prediction in solid organ transplant recipients. Methods: Two independent researchers conducted a comprehensive review of studies examining analytical models that optimize tacrolimus dosing, searching Medline, Scopus, Embase, Web of Science, and PubMed. Results: In total, 115 studies met the inclusion criteria. Pharmacokinetic models (74 studies), particularly two-compartment with Bayesian forecasting, were most frequently used. Machine learning (ML) approaches, with increasing adoption, have demonstrated promising improved predictive accuracy. Key predictive variables included CYP3A5 genotype, hematocrit levels, post-operative days, and weight; however, the significance of genomic features seemed to diminish progressively as therapeutic drug monitoring calibrates dosing in the months following post-transplant. Only ten studies performed external validation, and none incorporated adherence data or predicted long-term graft outcomes. Conclusions: Clinical deployment of predictive models for tacrolimus dosing remains uncommon. In research, pharmacokinetic models remain prevalent, with ML approaches showing early incremental promise. Limited external validation raises generalizability concerns. Future research should prioritize outcome-based evaluation metrics rather than error metrics.Keywords
Funding Information
- Ottawa Hospital Academic Medical Organization (TOHAMO) Innovation Fund
- Ottawa Hospital Division of Medicine ELEVATE grant
This publication has 150 references indexed in Scilit:
- Model‐Informed Reinforcement Learning for Enabling Precision Dosing Via Adaptive DosingClinical Pharmacology & Therapeutics, 2024
- Reinforcement Learning and PK‐PD Models Integration to Personalize the Adaptive Dosing Protocol of Erdafitinib in Patients with Metastatic Urothelial CarcinomaClinical Pharmacology & Therapeutics, 2024
- Genotype‐Guided Model for Prediction of Tacrolimus Initial Dosing After Lung TransplantationThe Journal of Clinical Pharmacology, 2024
- Bayesian optimization of tacrolimus exposure in stable kidney transplant patientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023
- American Society for Clinical Pharmacology and TherapeuticsClinical Pharmacology & Therapeutics, 2023
- Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant RecipientsThe Journal of Clinical Pharmacology, 2022
- Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2022
- Predicting model‐informed precision dosing: A test‐case in tacrolimus dose adaptation for kidney transplant recipientsCPT: Pharmacometrics & Systems Pharmacology, 2022
- Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European AncestryThe Journal of Clinical Pharmacology, 2021
- Tacrolimus Exposure Prediction Using Machine LearningClinical Pharmacology & Therapeutics, 2020